Exactech received FDA 510(k) clearance to market the Vantage™ Total Ankle, marking its entry in the foot and ankle segment. Targeted clinical evaluation will commence during mid-2016, with full launch slated for 1Q17.
The system incorporates the press-fit bone cage design used in the Equinoxe shoulder system, developed to support initial and long-term fixation.
Exactech received FDA 510(k) clearance to market the Vantage™ Total Ankle, marking its entry in the foot and ankle segment. Targeted clinical evaluation will commence during mid-2016, with full launch slated for 1Q17.
The system incorporates the press-fit bone cage design used in the Equinoxe shoulder system, developed to support initial and...
Exactech received FDA 510(k) clearance to market the Vantage™ Total Ankle, marking its entry in the foot and ankle segment. Targeted clinical evaluation will commence during mid-2016, with full launch slated for 1Q17.
The system incorporates the press-fit bone cage design used in the Equinoxe shoulder system, developed to support initial and long-term fixation.
Copy to clipboard 
